Advanced Nutriceuticals Recalls GHK-CU Vials Due to Sterility Concerns
Advanced Nutriceuticals is recalling GHK-CU vials because production processes cannot assure sterility. The product was distributed in seven states.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The agency classified this as an FDA Class II recall. Per the rubric, FDA Class II recalls involving significant risks such as sterility failures in injectable products are categorized as Severe.
Plain-English summary
Advanced Nutriceuticals, LLC is recalling GHK-CU, 10 MG/ML, 5 ML vials manufactured for The Guyer Institute of Molecular Medicine in Indianapolis, IN. The recall is due to concerns with production processes that cannot assure the sterility of products intended to be sterile.
The affected product is identified by Lot #1030202010 and has an expiration date of 11/30/2020. The recall covers one vial per unit. The product was distributed in California, Colorado, Florida, Indiana, Kentucky, Ohio, and Texas.
Consumers should stop using the recalled product and contact Advanced Nutriceuticals, LLC for further instructions or a refund.
The recalled product
- Product
- GHK-CU, 10 MG/ML, 5 ML vial, The Guyer Institute of Molecular Medicine, Indianapolis, IN
- Manufacturer
- Advanced Nutriceuticals, LLC
- Category
- Drug — Injectable
- Affected units
- 1
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot #1030202010
- Exp 11/30/2020
Distribution
Part of a larger recall action
This product is one of 17 recalled by Advanced Nutriceuticals, LLC under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 17 products in this recall →Related recalls
Same manufacturer · Advanced Nutriceuticals, LLC
See all →- SeverePT-141 Injection Recalled Due to Sterility Assurance Concerns
FDA (Drugs) · 2020-12-23
- SevereFDA Recalls NANDROLONE Injections Due to Sterility Concerns
FDA (Drugs) · 2020-12-23
- SevereAdvanced Nutriceuticals Recalls GHRP Vials Due to Sterility Concerns
FDA (Drugs) · 2020-12-23
- SevereFDA Recalls Cerebrolysin Vials Due to Sterility Concerns
FDA (Drugs) · 2020-12-23
- SevereFDA Recalls Thymosin Beta-4 Vials Due to Sterility Concerns
FDA (Drugs) · 2020-12-23
Same hazard · sterility failure
See all →- SevereROHTO DIGI-EYE Eye Drops Recalled Over Sterility Assurance Gap
FDA (Drugs) · 2026-07-29
- HighROHTO DRY-AID Eye Drops Recalled Due to Sterility Concerns
FDA (Drugs) · 2026-07-29
- SevereTransvenous Pacing Electrode Tray with Bipolar Balloon Pacing Electrode Recalled
FDA (Devices) · 2026-07-22
- SevereArterial Line Kit with Lidocaine HCL Injection Fails Sterility Testing
FDA (Devices) · 2026-07-22
- SevereOne-Piece Introducer Tray kits recalled for sterility failure
FDA (Devices) · 2026-07-22